AUPH Aurinia Pharmaceuticals Inc.: institutional ownership and insider trading
298 funds reported holding $1.44B of Aurinia Pharmaceuticals Inc. in their latest 13F filings; in Q2 2026 funds net bought $104M, with 44 new positions and 25 funds selling out; over the last 12 months insiders bought $25.1M and sold $546K on the open market.
Famous investors holding AUPH
- Two Sigma (Two Sigma Investments): $58.8M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $26.3M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $23.9M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $7.89M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $4.15M, 0.0% of the portfolio
Largest institutional holders of AUPH
- TANG CAPITAL MANAGEMENT LLC — $221M
- BlackRock, Inc. (BLK) — $139M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $95.4M
- NEA Management Company, LLC — $67.4M
- TWO SIGMA INVESTMENTS, LP — $58.8M
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — $55.4M
- STATE STREET CORP (STT, STT-PG) — $43.9M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $39.2M
- MARSHALL WACE, LLP — $34.7M
- GEODE CAPITAL MANAGEMENT, LLC — $28.9M
Recent AUPH insider trades
- Sep 10, 2026: Robertson Stephen P. sold 11,939 shares ($190K)
- Aug 21, 2026: Robertson Stephen P. sold 20,975 shares ($356K)
- Jun 2, 2026: Tang Kevin bought 814,606 shares ($12.5M)
- Mar 3, 2026: Tang Kevin bought 900,000 shares ($12.7M)
5%+ owners
- TANG CAPITAL MANAGEMENT, LLC: 10.0% (Schedule 13D/A, filed Jun 4, 2026)